PDS Biotechnology CorporationFLORHAM PARK, N.J., Sept. 23, 2022 (Globe NEWSWIRE) -- PDS Biotechnology Company (Nasdaq: PDSB), a clinical-phase immunotherapy corporation...
Beneath
LOS ANGELES--(Enterprise WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical firm, introduced that on June 3, 2022, the Compensation Committee of...
